Treatment of radiation-damaged bone marrow using galactosyl ceramides
Patent Number: 5767092
Date of First Priority Issue: Thursday July 15th, 1993
Date Issued: Saturday May 16th, 1998
Assignee: Kirin Beer Kabushiki Kaisha (Tokyo-to, JP)
Inventors: Koezuka, Yasuhiko (Takasaki, JP); Kabaya, Koji (Takasaki, JP); Motoki, Kazuhiro (Takasaki, JP)
From Class: Expansion
Comments: No comments
The composition of matter described in this patent is actually a stimulator of NKT cells. In this patent, the composition, alpha galactosyl ceramide is described for the use of protecting the hematopoietic stem cell compartment from radiation or chemotherapy. It is unknown if these effects are directly mediated on the CD34+ hematopoietic stem cells, or if they are indirect through the activation of NKT cells.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.